Antiestrotrophic Mechanisms of Alphafetoprotein Peptides
甲胎蛋白肽的抗雌激素机制
基本信息
- 批准号:6457419
- 负责人:
- 金额:$ 13.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-05-01 至 2006-04-30
- 项目状态:已结题
- 来源:
- 关键词:MCF7 cell alpha fetoprotein biological signal transduction breast neoplasms cathepsin D complementary DNA enzyme inhibitors estrogen inhibitor estrogen receptors gene expression growth factor receptors insulinlike growth factor mannose 6 phosphate microarray technology mitogen activated protein kinase molecular pathology neoplastic cell phosphatidylinositol 3 kinase protein structure function receptor expression synthetic peptide
项目摘要
DESCRIPTION: (provided by the applicant) Alphafetoprotein (AFP) and synthetic
peptide derivatives are potent antiestrotrophic agents with significant
potential as a novel class of therapeutic agents against breast cancer. The
activity of the full-length protein is localized within an eight amino acid
peptide derived from the native human alphafetoprotein elevating this synthetic
peptide to a primary target for development. AFP peptide blocks the
estrogen-stimulated growth of normal and neoplastic tissues. The anti-oncotic
activity of AFP and its derivative peptides is unique to estrogen
receptor-containing cells in vivo and in vitro. Until recently, much effort has
been invested into the study of the antiestrotrophic activity of AFP fragments
and peptides, with the focus on identification of the protein active site, yet
very little is known about the cellular mechanism of AFP peptide action. The
goal of this project is to discover the fundamental molecular mechanism(s) of
AFP peptide activity. To accomplish this goal, it is necessary to identify the
components of the cellular machinery involved in AFP action so that we may
understand the biochemical and molecular basis of AFP peptide activity. The
result of this work is expected to contribute to the development of novel
therapeutic targets and will provide valuable information concerning the
potential of AFP peptides as agents in the prevention, treatment, and diagnosis
of breast cancer.
描述:(由申请人提供)甲胎蛋白(AFP)和合成
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen M. Festin其他文献
Stephen M. Festin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen M. Festin', 18)}}的其他基金
相似海外基金
Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines
改造甲胎蛋白和磷脂酰肌醇蛋白聚糖 3 以开发肝癌 (HCC) 疫苗
- 批准号:
8693488 - 财政年份:2014
- 资助金额:
$ 13.95万 - 项目类别:
Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines
改造甲胎蛋白和磷脂酰肌醇蛋白聚糖 3 以开发肝癌 (HCC) 疫苗
- 批准号:
9231438 - 财政年份:2014
- 资助金额:
$ 13.95万 - 项目类别:
Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines
改造甲胎蛋白和磷脂酰肌醇蛋白聚糖 3 以开发肝癌 (HCC) 疫苗
- 批准号:
8827287 - 财政年份:2014
- 资助金额:
$ 13.95万 - 项目类别:
Suppression of alpha-fetoprotein related hepatocellular proliferation and hepatocellular carcinogenesis in nonalcoholic steatohepatitis
抑制非酒精性脂肪性肝炎中甲胎蛋白相关的肝细胞增殖和肝细胞癌变
- 批准号:
24590981 - 财政年份:2012
- 资助金额:
$ 13.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Induktion einer spezifischen Immunantwort gegen alpha-Fetoprotein mittels AFP-Adenovirus-transfizierter dendritischer Zellen in vitro und in vivo zur Therapie des HCC
使用 AFP 腺病毒转染的树突状细胞在体外和体内诱导针对甲胎蛋白的特异性免疫应答以治疗 HCC
- 批准号:
5417539 - 财政年份:2004
- 资助金额:
$ 13.95万 - 项目类别:
Research Grants
Analysis of alpha-fetoprotein immune responses in patient with hepatocellular carcinoma
肝细胞癌患者甲胎蛋白免疫反应分析
- 批准号:
5378445 - 财政年份:2002
- 资助金额:
$ 13.95万 - 项目类别:
Research Grants
Alpha-Fetoprotein spezifische Immuntherapie des hepatozellulären Karzinoms (C 5)
肝细胞癌(C 5)的甲胎蛋白特异性免疫治疗
- 批准号:
5205850 - 财政年份:2000
- 资助金额:
$ 13.95万 - 项目类别:
Collaborative Research Centres
ALPHA FETOPROTEIN ENHANCERS/LIVER SPECIFIC TRANSCRIPTION
α胎蛋白增强剂/肝脏特异性转录
- 批准号:
2487123 - 财政年份:1998
- 资助金额:
$ 13.95万 - 项目类别:
STEROID HORMONES, ALPHA FETOPROTEIN AND BREAST CANCER
类固醇激素、α 胎蛋白和乳腺癌
- 批准号:
2437805 - 财政年份:1997
- 资助金额:
$ 13.95万 - 项目类别:
IN VITRO RECONSTITUTION OF ALPHA FETOPROTEIN REGULATION
α 胎蛋白调节的体外重建
- 批准号:
6386241 - 财政年份:1997
- 资助金额:
$ 13.95万 - 项目类别: